Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

A 9-year-old girl with alopecia areata had successful hair regrowth using bimatoprost after other treatments failed.

Platelet-Rich Plasma and stem cell therapy can increase hair count and density, but the best method for preparation and treatment still needs to be determined.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Using methods like lasers and microneedling with drugs can improve hair regrowth for alopecia, but more research is needed on safety and best practices.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

People with alopecia areata often have lower vitamin D levels than healthy people.